“…YAP, a negative regulator of the HIPPO pathway involved in organ size and cell proliferation (Wu, Huang, Dong, & Pan, 2003), is enriched in the nucleus of KRT141 cells in the ducts during early stages of SG development (E13.5). Ablation of Yap, and thus activation of the HIPPO pathway, in KRT51/KRT141 cells before SG initiation reduces the production of Epiregulin, an ErbB receptor ligand which is involved in cell fate control (Gregorieff, Liu, Inanlou, Khomchuk, & Wrana, 2015) and is required for KRT51/KRT141 cell expansion, thereby perturbing epithelial branching and duct formation (Szymaniak et al, 2017) (Wright et al, 2015) and similarly, blocking RA signaling in isolated epithelia with the pan-RAR antagonist BMS 493 results in reduced branching morphogenesis (Wright et al, 2015) and repressed cell proliferation (Abashev, Metzler, Wright, & Sandell, 2017 (Figure 3), it remains unclear if cells that co-express KRT5 and 14 or those that solely express one but not the other keratin continue to contribute to the different epithelial lineages.…”